Ghrelin, leptin, and glycemic control after sleeve gastrectomy versus Roux-en-Y gastric bypass—results of a randomized clinical trial

Surgery for Obesity and Related Diseases

Volumn 13, Issue 2, 2017, Pages 181-188

  Kalinowski, Piotr ^a   Paluszkiewicz, Rafał ^a   Wróblewski, Tadeusz ^a   Remiszewski, Piotr ^a   Grodzicki, Mariusz ^a   Bartoszewicz, Zbigniew ^a   Krawczyk, Marek ^a  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

Bariatric surgery; Gastric bypass; Ghrelin; Glucose metabolism; Randomized trial; Sleeve gastrectomy

Indexed keywords

C PEPTIDE; GHRELIN; GLUCAGON; GLUCOSE; GLYCOSYLATED HEMOGLOBIN; LEPTIN;

ADULT; ANTHROPOMETRIC PARAMETERS; ARTICLE; BIOCHEMICAL ANALYSIS; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; DIET RESTRICTION; FEMALE; GLUCOSE HOMEOSTASIS; GLUCOSE METABOLISM; GLYCEMIC CONTROL; HOMEOSTASIS MODEL ASSESSMENT; HORMONE BLOOD LEVEL; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MORBID OBESITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; ROUX-EN-Y GASTRIC BYPASS; SLEEVE GASTRECTOMY; WEIGHT REDUCTION; ADOLESCENT; BLOOD; COMPARATIVE STUDY; GASTRECTOMY; GASTRIC BYPASS SURGERY; GLUCOSE BLOOD LEVEL; HOMEOSTASIS; INSULIN RESISTANCE; LAPAROSCOPY; METABOLISM; OPERATION DURATION; PHYSIOLOGY; PROCEDURES; YOUNG ADULT;

ADOLESCENT; ADULT; BLOOD GLUCOSE; C-PEPTIDE; FEMALE; GASTRECTOMY; GASTRIC BYPASS; GHRELIN; GLUCAGON; GLYCATED HEMOGLOBIN A; HOMEOSTASIS; HUMANS; INSULIN RESISTANCE; LAPAROSCOPY; LEPTIN; MALE; MIDDLE AGED; OBESITY, MORBID; OPERATIVE TIME; PROSPECTIVE STUDIES; WEIGHT LOSS; YOUNG ADULT;

EID: 85008602007     PISSN: 15507289     EISSN: 18787533     Source Type: Journal    
DOI: 10.1016/j.soard.2016.08.025     Document Type: Article

References (30)

1. [1] Maggard, M.A., Shugarman, L.R., Suttorp, M., et al. Meta-analysis: surgical treatment of obesity. Ann Intern Med 142:7 (2005), 547–559.
2. [2] Buchwald, H., Oien, D.M., Metabolic/Bariatric Surgery Worldwide 2008. Obes Surg 19:12 (2009), 1605–1611.
3. [3] le Roux, C.W., Aylwin, S.J., Batterham, R.L., et al. Gut hormone profiles following bariatric surgery favor an anorectic state, facilitate weight loss, and improve metabolic parameters. Ann Surg 243:1 (2006), 108–114.
4. [4] Nguyen, N.T., Nguyen, B., Gebhart, A., Hohmann, S., Changes in the makeup of bariatric surgery: a national increase in use of laparoscopic sleeve gastrectomy. J Am Coll Surg 216:2 (2013), 252–257.
5. [5] Kojima, M., Hosoda, H., Date, Y., Nakazato, M., Matsuo, H., Kangawa, K., Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 402:6762 (1999), 656–660.
6. [6] Gnanapavan, S., Kola, B., Bustin, S.A., et al. The tissue distribution of the mRNA of ghrelin and subtypes of its receptor, GHS-R, in humans. J Clin Endocrinol Metab 87:6 (2002), 2988–2991.
7. [7] Morpurgo, P.S., Resnik, M., Agosti, F., Cappiello, V., Sartorio, A., Spada, A., Ghrelin secretion in severely obese subjects before and after a 3-week integrated body mass reduction program. J Endocrinol Invest 26:8 (2003), 723–727.
8. [8] Kotidis, E.V., Koliakos, G.G., Baltzopoulos, V.G., Ioannidis, K.N., Yovos, J.G., Papavramidis, S.T., Serum ghrelin, leptin and adiponectin levels before and after weight loss: comparison of three methods of treatment–a prospective study. Obes Surg 16:11 (2006), 1425–1432.
9. [9] Friedman, J.M., Halaas, J.L., Leptin and the regulation of body weight in mammals. Nature 395:6704 (1998), 763–770.
10. [10] Shintani, M., Ogawa, Y., Ebihara, K., et al. Ghrelin, an endogenous growth hormone secretagogue, is a novel orexigenic peptide that antagonizes leptin action through the activation of hypothalamic neuropeptide Y/Y1 receptor pathway. Diabetes 50:2 (2001), 227–232.
11. [11] Chen, L., Philippe, J., Unger, R.H., Glucagon responses of isolated α cells to glucose, insulin, somatostatin, and leptin. Endocr Pract 17:5 (2011), 819–825.
12. [12] Munzberg, H., Myers, M.G. Jr, Molecular and anatomical determinants of central leptin resistance. Nat Neurosci 8:5 (2005), 566–570.
13. [13] Yada, T., Dezaki, K., Sone, H., et al. Ghrelin regulates insulin release and glycemia: physiological role and therapeutic potential. Curr Diabetes Rev 4:1 (2008), 18–23.
14. [14] Paluszkiewicz, R., Kalinowski, P., Wróblewski, T., et al. Prospective randomized clinical trial of laparoscopic sleeve gastrectomy versus open Roux-en-Y gastric bypass for the management of patients with morbid obesity. Wideochir Inne Tech Malo Inwazyjne 7:4 (2012), 225–232.
15. [15] American Diabetes Association. Standards of medical care in diabetes−2012. Diabetes Care 35:Suppl 1 (2012), S11–S63.
16. [16] Buse, J.B., Caprio, S., Cefalu, W.T., et al. How do we define cure of diabetes?. Diabetes Care 32:11 (2009), 2133–2135.
17. [17] Matthews, D.R., Hosker, J.P., Rudenski, A.S., Naylor, B.A., Treacher, D.F., Turner, R.C., Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:7 (1985), 412–419.
18. [18] Nocca, D., Krawczykowsky, D., Bomans, B., et al. A prospective multicenter study of 163 sleeve gastrectomies: results at 1 and 2 years. Obes Surg 18:5 (2008), 560–565.
19. [19] Dapri, G., Vaz, C., Cadière, G.B., Himpens, J., A prospective randomized study comparing two different techniques for laparoscopic sleeve gastrectomy. Obes Surg 17:11 (2007), 1435–1441.
20. [20] Schulz, K.F., Grimes, D.A., Generation of allocation sequences in randomised trials: chance, not choice. Lancet 359:9305 (2002), 515–519.
21. [21] Koizumi, M., Hosoya, Y., Dezaki, K., et al. Serum ghrelin levels partially recover with the recovery of appetite and food intake after total gastrectomy. Surg Today 44:11 (2014), 2131–2137.
22. [22] Anderson, B., Switzer, N.J., Almamar, A., Shi, X., Birch, D.W., Karmali, S., The impact of laparoscopic sleeve gastrectomy on plasma ghrelin levels: a systematic review. Obes Surg 23:9 (2013), 1476–1480.
23. [23] Tymitz, K., Engel, A., McDonough, S., Hendy, M.P., Kerlakian, G., Changes in ghrelin levels following bariatric surgery: review of the literature. Obes Surg 21:1 (2011), 125–130.
24. [24] Faraj, M., Havel, P.J., Phélis, S., Blank, D., Sniderman, A.D., Cianflone, K., Plasma acylation-stimulating protein, adiponectin, leptin, and ghrelin before and after weight loss induced by gastric bypass surgery in morbidly obese subjects. J Clin Endocrinol Metab 88:4 (2003), 1594–1602.
25. [25] Lin, E., Gletsu, N., Fugate, K., et al. The effects of gastric surgery on systemic ghrelin levels in the morbidly obese. Arch Surg 139:7 (2004), 780–784.
26. [26] Buchwald, H., Estok, R., Fahrbach, K., et al. Weight and type 2 diabetes after bariatric surgery: systemic review and meta-analysis. Am J Med 122:3 (2009), 248–256.
27. [27] Peterli, R., Borbély, Y., Kern, B., et al. Early results of the Swiss Multicentre Bypass or Sleeve Study (SM-BOSS): a prospective randomized trial comparing laparoscopic sleeve gastrectomy and Roux-en-Y gastric bypass. Ann Surg 258:5 (2013), 690–694.
28. [28] Schauer, P.R., Bhatt, D.L., Kirwan, J.P., et al. Bariatric surgery versus intensive medical therapy for diabetes−3-year outcomes. N Engl J Med 370:21 (2014), 2002–2013.
29. [29] Aarts, E.O., Janssen, J., Janssen, I.M., Berends, F.J., Telting, D., de Boer, H., Preoperative fasting plasma C-peptide level may help to predict diabetes outcome after gastric bypass surgery. Obes Surg 23:7 (2013), 867–873.
30. [30] Kirchner, H., Heppner, K.M., Holland, J., Kabra, D., Tschöp, M.H., Pfluger, P.T., Ablation of ghrelin O-acyltransferase does not improve glucose intolerance or body adiposity in mice on a leptin-deficient ob/ob background. PLoS One, 8(4), 2013, e61822.